OvaCis
Commercial- Indications
- Ovarian cyst diagnosis
Company intelligence / Profile preview
INEX Innovate has commercialized at least five diagnostic tests and seven laboratory workflows addressing unmet needs in women’s and fetal health. The company pivoted to provide COVID‑19 RT-PCR testing during the pandemic. It has received industry recognition including the Frost & Sullivan ‘Singapore Clinical Laboratories in Women’s Health Entrepreneurial Company of the Year Award’. No detailed clinical trial results are published.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INEX Innovate.